Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.
Ninety-three representative, recent clinical isolates of Streptococcus pneumoniae were examined for susceptibility to 9 antimicrobial drugs utilizing Mueller-Hinton agar (MHA) enriched with sheep blood and a hypercapnic atmosphere of incubation. One isolate was resistant to penicillin G (minimum inhibitory concentration, MIC = 2 micrograms/ml) and 6 isolates were of intermediate susceptibility to penicillin G (MICs = 0.125-0.25 microgram/ml). The penicillin-G-resistant isolate was also resistant to cefuroxime (MIC = 4 micrograms/ml) and of intermediate susceptibility to cefotaxime (MIC = 1 microgram/ml). This isolate was resistant to chloramphenicol (MIC = 16 micrograms/ml) as well. All 93 isolates were susceptible to teicoplanin and vancomycin. Two isolates each were resistant (MICs = 16 micrograms/ml) or moderately susceptible (MICs = 8 micrograms/ml) to chloramphenicol. Eight isolates were resistant to doxycycline (MICs > or = 8 micrograms/ml), whereas 2 isolates were of intermediate susceptibility to this antibiotic (MICs = 4 micrograms/ml). Three isolates were resistant to erythromycin (MICs > or = 4 micrograms/ml), and 2 isolates showed reduced susceptibility to erythromycin (MICs = 2 micrograms/ml). Chocolatized MHA antagonized the activity of teicoplanin and vancomycin against pneumococcal isolates. Haemophilus test and Wilkins-Chalgren media failed to support optimal growth of all pneumococcal isolates.
Traub
W H
WH
Institut für Medizinische Mikrobiologie und Hygiene, Universität des Saarlandes, Homburg/Saar, Germany.
Leonhard
B
B
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002439:Cefotaxime / Q000494:pharmacology; D002444:Cefuroxime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D004318:Doxycycline / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D010068:Oxacillin / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D017334:Teicoplanin / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D017334:Teicoplanin; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D004318:Doxycycline; D002439:Cefotaxime; D002444:Cefuroxime; D010400:Penicillin G; D010068:Oxacillin